ethinylestradiol-3-sulfate has been researched along with fosfestrol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiedler, R; Klebingat, KJ; Lorenz, G; Panzig, E; Steinhauser, I | 1 |
| Dörner, G; Rohde, W; Schnorr, D; Stahl, F | 1 |
| Schott, H; Zade, W | 1 |
1 trial(s) available for ethinylestradiol-3-sulfate and fosfestrol
| Article | Year |
|---|---|
[Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron].
Topics: Aged; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Estramustine; Ethinyl Estradiol; Humans; Immunity, Cellular; Macrophages; Male; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation | 1987 |
2 other study(ies) available for ethinylestradiol-3-sulfate and fosfestrol
| Article | Year |
|---|---|
[Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Diethylstilbestrol; Ethinyl Estradiol; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone | 1987 |
[Liver damage in hormone therapy of prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Diethylstilbestrol; Ethinyl Estradiol; Humans; Liver Function Tests; Male; Middle Aged; Prostatic Neoplasms | 1987 |